Speaker illustration

Doctor Preston Mason

Brigham And Womens Hospital, Harvard Medical School, Boston (United States of America)

Dr. R. Preston Mason is a faculty member of the Cardiovascular Division at Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts, USA. Dr Mason is also President and Founder of Elucida Research. He has received many awards for his research in cardiovascular pharmacology and teaching over the past 30 years, including an honorary doctorate in science. He received a full scholarship for graduate and medical programs (MD/PhD) at the University of Connecticut School of Medicine. Prior to coming to Boston, he was on the faculties of the University of Connecticut School of Medicine and the Medical College of Pennsylvania (now Drexel University) where he was nominated for full professor. Dr. Mason has authored or co-authored more than 250 scientific articles and abstracts.

Omega-3 fatty acids differentially reduced expression of neutrophil degranulation-associated proteins in endothelial cells during IL-6 exposure

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids, Metabolism

Session: Basic science e-posters

Thumbnail

Eicosapentaenoic acid inhibits lipopolysaccharide (LPS)-induced nitrite production and cytokine release from J774 macrophages

Event: ESC Congress 2021 - The Digital Experience

Topic: Leukocytes, Inflammation, Immunity

Session: Basic science e-posters

Thumbnail

Omega-3 fatty acids differentially alter the expression of detoxification enzymes and nitric oxide bioavailability in endothelial cells during IL-6 exposure

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids, Metabolism

Session: Basic science e-posters

Thumbnail

Omega-3 fatty acids - Why they are not all the same?

Event: ESC CONGRESS 2019

Topic: Risk Factors and Prevention, Other

Session: Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Thumbnail

Omega-3 fatty acids - Why they are not all the same?

Event: ESC CONGRESS 2019

Topic: Risk Factors and Prevention, Other

Session: Reducing residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Thumbnail

This platform is supported by

logo Novo Nordisk